GAP43 and epilepsy: A study of lithium–pilocarpine-induced epilepsy in rats found that treatment with LEV reduced the GAP43 levels in a dose-related fashion, theorizing that reduction in axonal sprouting may be a mechanism for LEV's antiepileptogenic functions (57).